Matinas BioPharma Holdings Inc (MTNB)

US · Healthcare · Biotechnology

$2.37-2.07%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-1.3M

EPS

$-0.21

Market cap

$2.8M

Forward P/E

0.0

P/B

1.43

Book value

$4.21

EPS (TTM)

$-17.55

52-week high

$28.95

52-week low

$2.26

50-day MA

$3.06

200-day MA

$7.58

Beta

2.08

Analysts rate Matinas BioPharma Holdings Inc a hold (0 buy, 2 hold, 0 sell out of 2) with an average price target of $30.00.

Insiders

23.75%

Institutions

2.21%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Matinas BioPharma Holdings Inc — free to start.

Data updated 2026-10-19.